NO951547L - Fremgangsmåte for fremstilling av krystaller av veksthormon og krystaller fremstilt ved fremgangsmåten - Google Patents

Fremgangsmåte for fremstilling av krystaller av veksthormon og krystaller fremstilt ved fremgangsmåten

Info

Publication number
NO951547L
NO951547L NO951547A NO951547A NO951547L NO 951547 L NO951547 L NO 951547L NO 951547 A NO951547 A NO 951547A NO 951547 A NO951547 A NO 951547A NO 951547 L NO951547 L NO 951547L
Authority
NO
Norway
Prior art keywords
crystals
pct
growth hormone
date
alkyl
Prior art date
Application number
NO951547A
Other languages
English (en)
Other versions
NO320171B1 (no
NO951547D0 (no
Inventor
Ebba Florin-Robertsson
Elvy Hokby
Ronny Lundin
Sirkka Thome
Gertrud Westin-Sjodahl
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9203175A external-priority patent/SE9203175D0/xx
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Publication of NO951547L publication Critical patent/NO951547L/no
Publication of NO951547D0 publication Critical patent/NO951547D0/no
Publication of NO320171B1 publication Critical patent/NO320171B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/61Growth hormone [GH], i.e. somatotropin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/06Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Steroid Compounds (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO19951547A 1992-10-28 1995-04-24 Fremgangsmate for fremstilling av krystaller av veksthormon eller funksjonelle derivater derav, krystaller fremstilt ved fremgangsmaten, anvendelse av kjemisk forbindelse for fremstilling av krystallene, suspensjon for injeksjon, torrformulering og depotformulering som omfatter krystallene, anvendelse av krystallene for fremstilling av medikament og fremgangsmate for rensing av veksthormon. NO320171B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9203175A SE9203175D0 (sv) 1992-10-28 1992-10-28 Growth hormone
SE19939302278A SE9302278D0 (sv) 1992-10-28 1993-07-02 Growth hormone
PCT/SE1993/000885 WO1994010192A1 (en) 1992-10-28 1993-10-27 Process for manufacturing crystals of growth hormone and crystals thereby obtained

Publications (3)

Publication Number Publication Date
NO951547L true NO951547L (no) 1995-04-24
NO951547D0 NO951547D0 (no) 1995-04-24
NO320171B1 NO320171B1 (no) 2005-11-07

Family

ID=26661557

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19951547A NO320171B1 (no) 1992-10-28 1995-04-24 Fremgangsmate for fremstilling av krystaller av veksthormon eller funksjonelle derivater derav, krystaller fremstilt ved fremgangsmaten, anvendelse av kjemisk forbindelse for fremstilling av krystallene, suspensjon for injeksjon, torrformulering og depotformulering som omfatter krystallene, anvendelse av krystallene for fremstilling av medikament og fremgangsmate for rensing av veksthormon.

Country Status (14)

Country Link
US (1) US5734026A (no)
EP (1) EP0669934B1 (no)
JP (1) JP3470135B2 (no)
AT (1) ATE174602T1 (no)
AU (1) AU679012B2 (no)
CA (1) CA2147482C (no)
DE (1) DE69322654T2 (no)
DK (1) DK0669934T3 (no)
ES (1) ES2126660T3 (no)
FI (1) FI110609B (no)
HK (1) HK1013299A1 (no)
NO (1) NO320171B1 (no)
SE (1) SE9302278D0 (no)
WO (1) WO1994010192A1 (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9302278D0 (sv) * 1992-10-28 1993-07-02 Kabi Pharmacia Ab Growth hormone
US6500933B1 (en) 1997-09-05 2002-12-31 Altus Biologics Inc. Methods of preparing carbohydrate crosslinked glycoprotein crystals
ATE397013T1 (de) * 1997-09-05 2008-06-15 Altus Pharmaceuticals Inc Kohlenhydrat-vernetzte glykoproteinkristalle
US6380357B2 (en) * 1997-12-16 2002-04-30 Eli Lilly And Company Glucagon-like peptide-1 crystals
US6541606B2 (en) * 1997-12-31 2003-04-01 Altus Biologics Inc. Stabilized protein crystals formulations containing them and methods of making them
JP4417113B2 (ja) * 2002-02-20 2010-02-17 エミスフェアー・テクノロジーズ・インク Glp−1分子の投与方法
SE0202719D0 (sv) * 2002-09-13 2002-09-13 Pharmacia Ab Process for mfg crystals of growth hormone
KR20050090430A (ko) 2002-12-31 2005-09-13 알투스 파마슈티컬스 인코포레이티드 인간 성장 호르몬 결정 및 이것의 제조 방법
US20060286129A1 (en) * 2003-12-19 2006-12-21 Emisphere Technologies, Inc. Oral GLP-1 formulations
US7799273B2 (en) 2004-05-06 2010-09-21 Smp Logic Systems Llc Manufacturing execution system for validation, quality and risk assessment and monitoring of pharmaceutical manufacturing processes
US7444197B2 (en) 2004-05-06 2008-10-28 Smp Logic Systems Llc Methods, systems, and software program for validation and monitoring of pharmaceutical manufacturing processes
EP1976551A4 (en) * 2005-12-23 2009-12-30 Altus Pharmaceuticals Inc COMPOSITIONS COMPRISING COMPLEX PROTEIN CRYSTALS BY POLYCATIONS AND PROCESSING METHOD THEREOF

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69125035T2 (de) * 1990-06-04 1997-07-10 Schering Corp Verfahren zur herstellung von interferon-alpha-2 kristallen
WO1991019742A1 (en) * 1990-06-15 1991-12-26 Schering Corporation Crystalline interleukin-4
DK168790D0 (no) * 1990-07-13 1990-07-13 Novo Nordisk As
US5015627A (en) * 1990-07-20 1991-05-14 Smithkline Beecham Corporation Stabilized somatotropin for parenteral administration
SE9302278D0 (sv) * 1992-10-28 1993-07-02 Kabi Pharmacia Ab Growth hormone

Also Published As

Publication number Publication date
JP3470135B2 (ja) 2003-11-25
US5734026A (en) 1998-03-31
CA2147482C (en) 2003-09-23
NO320171B1 (no) 2005-11-07
WO1994010192A1 (en) 1994-05-11
AU679012B2 (en) 1997-06-19
AU5401194A (en) 1994-05-24
DE69322654T2 (de) 1999-06-17
ATE174602T1 (de) 1999-01-15
CA2147482A1 (en) 1994-05-11
ES2126660T3 (es) 1999-04-01
FI952021A0 (fi) 1995-04-27
NO951547D0 (no) 1995-04-24
FI952021A (fi) 1995-04-27
EP0669934B1 (en) 1998-12-16
DE69322654D1 (de) 1999-01-28
FI110609B (fi) 2003-02-28
SE9302278D0 (sv) 1993-07-02
HK1013299A1 (en) 1999-08-20
JPH08505127A (ja) 1996-06-04
DK0669934T3 (da) 1999-08-23
EP0669934A1 (en) 1995-09-06

Similar Documents

Publication Publication Date Title
NO951547L (no) Fremgangsmåte for fremstilling av krystaller av veksthormon og krystaller fremstilt ved fremgangsmåten
KR860002958A (ko) 살균제의 제법
DE69503604D1 (de) Stabilisierte orthokieselsäure enthaltende zubereitung sowie biologische zubereitung
CA2031766A1 (en) 2-substituted phenyl-2-oxazoline or thiazoline derivatives, process for producing the same and insecticides and acaricides containing the same
JPS6425763A (en) Pyrazoles and insecticide and acaricide containing said pyrazoles as active ingredient
TR199901055T2 (xx) Benzimidazol t�revlerinin kristalleri ve bunlar�n �retimi.
PT96324A (pt) Processo para a preparacao de compostos peptidicos e de composicoes farmaceuticas que os contem
PT87163A (pt) Process for preparing 1-phenyl-3-naphthalenyloxipropanamines
ES8802421A1 (es) Un procedimiento para la preparacion de un derivado de acido 5-imidazolcarboxilico
EP0194599A3 (en) Benzamide derivatives, process for producing the same, and soil fungicides containing the same
EP1468693A3 (en) Use of 2,6-di -alkyl-4-silyl-phenols for treating diabetes mellitus
EP0891975A4 (en) PYRAZOLES AND CHEMICALS FOR AGRICULTURE THAT CONTAIN THEM AS ACTIVE INGREDIENTS
IT1243801B (it) Intermedi per agenti chelanti con simmetria prefissata, e procedimentoper la loro preparazione
ES2118256T3 (es) Derivados de acido propenoico utiles como fungicidas.
DE69614841D1 (de) Verfahren zur Herstellung von Galanthaminderivate durch asymmetrische Reduktion
KR900018039A (ko) 피라졸 화합물과 그의 제조 및 용도
EP0551527B8 (en) Pyrroloazepine derivative
UA66832C2 (uk) Термодинамічно стійка модифікація і рематробану, спосіб одержання затравочних кристалів, спосіб одержання термодинамічно стійкої форми раматробану та фармацевтична композиція
GB1513840A (en) Phenoxycarboxylic acid aryloxy(thio)-carbonylaminomethyl esters and their use for regulating plant growth
JPS6434954A (en) Benzenecarboximidamide derivative and agricultural and horticultural fungicide
JPS6429301A (en) Bactericidal fungicidal compound composition
JPS6497A (en) 16-membered ring macrolide compound
JPS6463515A (en) 1-thiocarbamoyl-2-imidazolidinone compound, analgesic, anti-inflammatory drug and antipyretic containing said compound as active ingredient
JPS6485970A (en) Saccharoascorbic acid ester and production thereof
JO1871B1 (en) Innovative substituted benzimidazole compounds